Dr. Weil, Twinlab’s premium probiotic
This article was originally published in The Tan Sheet
Executive SummaryIdeaSphere, Inc., owner of Twinlab branded dietary supplements, and Andrew Weil, M.D., will develop and launch premium-branded probiotic products through a supply and licensing agreement with Ganeden Biotech, which specializes in digestive health bacteria. GanedenBC30 will be used in Dr. Weil's Daily Digestive Support Formula and Twinlab's Super Probiotic Formula supplements, the firms announce May 25. According to Ganeden, its probiotic strain is "able to survive the heat and pressure of manufacturing, has a long shelf life without refrigeration and can survive the acidic environment of the stomach"...
You may also be interested in...
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.
While contract manufacturer ABH Nature' complied with consent decree, Sen. Chuck Schumer says FDA is late in enforcing against noncompliant firms across the supplement sector. Other recent consumer health recalls include more OTC ranitidine tablets due to the potential carcinogen NDMA found in the heartburn ingredient and four versions of Sure 48HR Anti-Perspirant & Deodorant with labeling errors.
Bioresearchers at the Centers for Disease Control and Prevention are hoping that diagnostic platforms previously used to develop tests for outbreaks of other epidemic respiratory diseases, including SARS and MERS, can be built on to develop new diagnostics to detect more cases in the current coronavirus outbreak, US infectious disease authorities say. This comes as more patients are monitored around the US for the disease, and a Chicago woman returning from China tests positive.